naltrexone has been researched along with oxidopamine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 6 (42.86) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baraban, JM; Bhat, RV; Cole, AJ; Worley, PF | 1 |
Ceresoli, G; Groppetti, A; Mandelli, V; Parenti, M | 1 |
Di Chiara, G; Morelli, M | 1 |
Cavicchini, E; Ferri, S; Murari, G; Romualdi, P; Speroni, E | 1 |
Lendvai, B; Sándor, A; Sándor, NT | 1 |
Kameyama, T; Toyoshi, T; Ukai, M | 1 |
Pruett, SB; Wu, WJ | 1 |
Aston-Jones, G; Delfs, JM; Druhan, J; Zhu, Y | 1 |
Hyytiä, P; Kiianmaa, K; Koistinen, M; Tuomainen, P | 1 |
Benabid, AL; Berger, F; Buggia, V; Gilbert, F; Lévesque, D; Sgambato-Faure, V | 1 |
Aburada, M; Kase, Y; Murata, M; Omiya, Y; Suzuki, Y; Takeda, S; Yuzurihara, M | 1 |
Mabrouk, OS; Marti, M; Morari, M; Salvadori, S | 1 |
Booth, FW; Brown, JD; Kovarik, MC; Miller, DK; Ruegsegger, GN | 1 |
Ambriz-Tututi, M; Drucker-Colín, R; Gómez-Paz, A; Milán-Aldaco, D; Palomero-Rivero, M | 1 |
14 other study(ies) available for naltrexone and oxidopamine
Article | Year |
---|---|
Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268.
Topics: Animals; Apomorphine; Benzazepines; Brain; DNA-Binding Proteins; Early Growth Response Protein 1; Early Growth Response Protein 2; Electroshock; Haloperidol; Immediate-Early Proteins; Male; Morphine; Naltrexone; Nucleic Acid Hybridization; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Seizures; Substance Withdrawal Syndrome; Transcription Factors; Transcription, Genetic; Zinc Fingers | 1992 |
Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Corpus Striatum; Drug Interactions; Hydroxydopamines; Levodopa; Male; Morphine; Naltrexone; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Opioid | 1990 |
Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates.
Topics: Animals; Dynorphins; Enkephalins; Hydroxydopamines; Male; Medial Forebrain Bundle; Morphine; Movement; Naltrexone; Neural Pathways; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L.
Topics: Analgesics; Animals; Benzomorphans; Cannabis; Dose-Response Relationship, Drug; Enkephalin, Leucine; Haplorhini; Hydroxydopamines; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oxidopamine; Plant Extracts; Rats; Rats, Inbred Strains | 1986 |
Influence of selective opiate antagonists on striatal acetylcholine and dopamine release.
Topics: Acetylcholine; Animals; Corpus Striatum; Dopamine; Electric Stimulation; In Vitro Techniques; Male; Naloxone; Naltrexone; Narcotic Antagonists; Oxidopamine; Rats; Rats, Wistar | 1993 |
Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Naltrexone; Oxidopamine; Peptide Fragments; Receptors, Opioid | 1995 |
Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Animals; Azides; Benzodiazepines; Carbolines; Catecholamines; Corticosterone; Diazepam; Disease Models, Animal; Female; GABA-A Receptor Agonists; Glucocorticoids; Immunity, Cellular; Immunity, Innate; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mifepristone; Nadolol; Naltrexone; Neurosecretory Systems; Oxidopamine; Phentolamine; Picrotoxin; Propranolol; Receptors, GABA-A; Spleen; Sympathetic Nervous System | 1996 |
The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal.
Topics: Amygdala; Animals; Axonal Transport; Caudate Nucleus; Male; Microinjections; Morphine Dependence; Naloxone; Naltrexone; Neurons; Norepinephrine; Oxidopamine; Propranolol; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Thalamus; Tyrosine 3-Monooxygenase | 1999 |
Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.
Topics: Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ethanol; Male; Naltrexone; Narcotic Antagonists; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Self Administration; Serotonin; Sympatholytics | 2001 |
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Agents; AIDS-Related Complex; Amphetamine; Analgesics, Non-Narcotic; Animals; Antiparkinson Agents; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dynorphins; Dyskinesia, Drug-Induced; Functional Laterality; Homer Scaffolding Proteins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxidopamine; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2005 |
Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhiza; Male; Medicine, Kampo; Methysergide; Mice; Naltrexone; Narcotic Antagonists; Oxidopamine; Paeonia; Pain Measurement; Pain Threshold; Piperazines; Serotonin Antagonists; Sympatholytics; Tropanes; Yohimbine | 2005 |
The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
Topics: Amino Acids; Animals; Antiparkinson Agents; Benzimidazoles; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Neural Pathways; Oligopeptides; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substantia Nigra; Thalamus | 2009 |
Mu-opioid receptor inhibition decreases voluntary wheel running in a dopamine-dependent manner in rats bred for high voluntary running.
Topics: Animals; Cells, Cultured; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Feeding Behavior; Female; Injections, Intraperitoneal; Motivation; Motor Activity; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Receptors, Opioid, mu; RNA, Messenger; Running; Sedentary Behavior; Species Specificity; Volition | 2016 |
Intrastriatal Chromospheres' Transplant Reduces Nociception in Hemiparkinsonian Rats.
Topics: Animals; Cells, Cultured; Male; Microinjections; Naltrexone; Nociception; Oxidopamine; Pain Measurement; Parkinsonian Disorders; Rats; Substantia Nigra; Sulpiride | 2018 |